Loading clinical trials...

The Glycaemic Effects of Glucerna® in Critically Ill Patients. | Clinical Trials | Clareo Health

COMPLETEDNANCT02594865

The Glycaemic Effects of Glucerna® in Critically Ill Patients.

To investigate whether the administration of Glucerna achieves less glycaemic variability, defined as the mean absolute glucose (MAG) change, and better glycaemic control compared to a standard high-c...

Lead sponsor: PHJ van der Voort•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETEDPhase 4

Research of Exenatide for Overweight/Obese PCOS Patients With IGR

NCT03352869 · Polycystic Ovary Syndrome, Overweight and Obesity, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 27, 2016Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment100

Start dateSep 2015

Last updatedJun 27, 2016

Condition

Disorder of Glucose Regulation

Locations shown

Onze Lieve Vrouwe Gasthuis

Amsterdam, North Holland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 27, 2016Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions